Clinical Trial Update: Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of aliskiren and amlodipine on the renin-angiotensin system and lipid/carbohydrate metabolism in obese patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Obesity
• Hypertension

Drugs mentioned

• NORVASC (amlodipine besylate)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Abdominal Obesity | Phase 2 | Status: TERMINATED | Results posted: 2013-10-24